Terms: = Kidney tumors AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K
539 results:
1. RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma-like mesenchymal tumors.
Motta M; Barresi S; Pizzi S; Bifano D; Lopez Marti J; Garrido-Pontnou M; Flex E; Bruselles A; Giovannoni I; Rotundo G; Fragale A; Tirelli V; Vallese S; Ciolfi A; Bisogno G; Alaggio R; Tartaglia M
J Pathol; 2024 Jun; 263(2):166-177. PubMed ID: 38629245
[TBL] [Abstract] [Full Text] [Related]
2. [Total polyphenols of Cydonia oblonga inhibited proliferation and migration of renal cancer cells by pi3k/Akt/mTOR pathway].
Abudurousuli K; Han MY; Hailati S; Maihemuti N; Talihati Z; Nueraihemaiti N; Dilimulati D; Baishan A; Aikebaier A; Zhou WT
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1052-1063. PubMed ID: 38621912
[TBL] [Abstract] [Full Text] [Related]
3. VHL governs m6A modification and PIK3R3 mRNA stability in clear cell renal cell carcinomas.
Lee H; Zhuang L; Gan B
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618953
[TBL] [Abstract] [Full Text] [Related]
4. Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesis.
Zhang C; Yu M; Hepperla AJ; Zhang Z; Raj R; Zhong H; Zhou J; Hu L; Fang J; Liu H; Liang Q; Jia L; Liao C; Xi S; Simon JM; Xu K; Liu Z; Nam Y; Kapur P; Zhang Q
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618952
[TBL] [Abstract] [Full Text] [Related]
5. VHL mutation drives human clear cell renal cell carcinoma progression through pi3k/AKT-dependent cholesteryl ester accumulation.
Zhang S; Fang T; He Y; Feng W; Yu Z; Zheng Y; Zhang C; Hu S; Liu Z; Liu J; Yu J; Zhang H; He A; Gong Y; He Z; Yang K; Xi Z; Yu W; Zhou L; Yao L; Yue S
EBioMedicine; 2024 May; 103():105070. PubMed ID: 38564827
[TBL] [Abstract] [Full Text] [Related]
6. Designing a predictive Framework: Immune-Related Gene-Based nomogram and prognostic model for kidney renal papillary cell carcinoma.
Lim A; Edderkaoui M; Zhang Y; Wang Q; Wang R; Pandol SJ; Ou Y
Int Immunopharmacol; 2024 Apr; 131():111878. PubMed ID: 38493693
[TBL] [Abstract] [Full Text] [Related]
7. MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis.
Tao J; Cui J; Xu Y; Fan Y; Hong G; Zhou Q; Wang G; Li L; Han Y; Xu C; Wang W; Cai S; Zhang X
Aging (Albany NY); 2024 Jan; 16(3):2090-2122. PubMed ID: 38301040
[No Abstract] [Full Text] [Related]
8. Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis.
Rosellini M; Mollica V; Marchetti A; Coluccelli S; Giunchi F; Tassinari E; Ricci C; Fiorentino M; Tallini G; De Biase D; Massari F
Pathol Res Pract; 2024 Feb; 254():155142. PubMed ID: 38277752
[TBL] [Abstract] [Full Text] [Related]
9. Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined pi3k and ATR/ATM Inhibitors in Colorectal Cancer.
Zhang M; Li X; Herman JG; Gao A; Wang Q; Yao Y; Shen F; He K; Guo M
Clin Transl Gastroenterol; 2024 Mar; 15(3):e00682. PubMed ID: 38235705
[TBL] [Abstract] [Full Text] [Related]
10. SLFN11 promotes clear cell renal cell carcinoma progression via the pi3k/AKT signaling pathway.
Wang HX; Zhao ZP; Du XY; Peng SL; Xu HY; Tang W; Yang L
Med Oncol; 2024 Jan; 41(2):54. PubMed ID: 38206539
[TBL] [Abstract] [Full Text] [Related]
11. NSD2 modulates Drp1-mediated mitochondrial fission in chronic renal allograft interstitial fibrosis by methylating STAT1.
Zhang J; Xie W; Ni B; Li Z; Feng D; Zhang Y; Han Q; Zhou H; Gu M; Tan R
Pharmacol Res; 2024 Feb; 200():107051. PubMed ID: 38190956
[TBL] [Abstract] [Full Text] [Related]
12. TYROBP as a molecular target in cholangiocarcinoma, renal cancer and abdominal aortic aneurysm.
Jia W; Chen L; Hou S; Kang C; Deng H
Medicine (Baltimore); 2024 Jan; 103(1):e36843. PubMed ID: 38181271
[TBL] [Abstract] [Full Text] [Related]
13. Effects of Purine Metabolism-Related
Yin W; Wang JH; Liang YM; Liu KH; Chen Y; Chen YS
Front Biosci (Landmark Ed); 2023 Dec; 28(12):354. PubMed ID: 38179759
[TBL] [Abstract] [Full Text] [Related]
14. ZNF471 Interacts with BANP to Reduce Tumour Malignancy by Inactivating pi3k/AKT/mTOR Signalling but is Frequently Silenced by Aberrant Promoter Methylation in Renal Cell Carcinoma.
Wang X; Yao L; Li Z; Zhang J; Ruan M; Mulati Y; Gan Y; Zhang Q
Int J Biol Sci; 2024; 20(2):643-663. PubMed ID: 38169650
[No Abstract] [Full Text] [Related]
15. Doxycycline hydrochloride inhibits the progress of malignant rhabdoid tumor of kidney by targeting MMP17 and MMP1 through pi3k-Akt signaling pathway.
Mi T; Zhang Z; Zhanghuang C; Jin L; Tan X; Liu J; Wu X; Li M; Wang J; Wang Z; Guo P; He D
Eur J Pharmacol; 2024 Feb; 964():176291. PubMed ID: 38158115
[TBL] [Abstract] [Full Text] [Related]
16. Molecular Expression and Prognostic Implications of Krüppel-Like Factor 3 (KLF3) in Clear Cell Renal Cell Carcinoma.
Wan B; Zhang W; Deng X; Lu Y; Zhang Z; Yang Y
Crit Rev Eukaryot Gene Expr; 2024; 34(2):45-59. PubMed ID: 38073441
[TBL] [Abstract] [Full Text] [Related]
17. A Network Pharmacology and Molecular-Docking-Based Approach to Identify the Probable Targets of Short-Chain Fatty-Acid-Producing Microbial Metabolites against kidney Cancer and Inflammation.
Karim MR; Morshed MN; Iqbal S; Mohammad S; Mathiyalagan R; Yang DC; Kim YJ; Song JH; Yang DU
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002360
[TBL] [Abstract] [Full Text] [Related]
18. SEL1L3 as a link molecular between renal cell carcinoma and atherosclerosis based on bioinformatics analysis and experimental verification.
Wang H; Ma X; Li S; Ni X
Aging (Albany NY); 2023 Nov; 15(22):13150-13162. PubMed ID: 37993256
[TBL] [Abstract] [Full Text] [Related]
19. S100A16 cooperates with DEPDC1 to promote the progression and angiogenesis of nephroblastoma through pi3k/Akt/mTOR pathway.
Geng G; Xu Y; Li Q; Li Q; Yuan L; Dong M; Ming M
Pol J Pathol; 2023; 74(3):182-193. PubMed ID: 37955537
[TBL] [Abstract] [Full Text] [Related]
20. High PAQR4 mRNA Expression May Play a Key Role in Prognosis of kidney Renal Papillary Cell Carcinoma.
Liu C; Cai W; Tang P; Li C
Ann Clin Lab Sci; 2023 Sep; 53(5):701-711. PubMed ID: 37945022
[TBL] [Abstract] [Full Text] [Related]
[Next]
